BioNTech SE
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioNTech SE and other ETFs, options, and stocks.About BNTX
BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators.
CEOUgur Sahin
CEOUgur Sahin
Employees6,772
Employees6,772
HeadquartersMainz, Rheinland-Pfalz
HeadquartersMainz, Rheinland-Pfalz
Founded2008
Founded2008
Employees6,772
Employees6,772
BNTX Key Statistics
Market cap24.98B
Market cap24.98B
Price-Earnings ratio-65.61
Price-Earnings ratio-65.61
Dividend yield—
Dividend yield—
Average volume567.05K
Average volume567.05K
High today$105.41
High today$105.41
Low today$102.34
Low today$102.34
Open price$104.03
Open price$104.03
Volume551.24K
Volume551.24K
52 Week high$129.27
52 Week high$129.27
52 Week low$81.20
52 Week low$81.20
BNTX News
TipRanks 5d
Bristol-Myers Squibb and BioNTech Launch New Colorectal Cancer StudyBristol-Myers Squibb Company ((BMY)), Biontech Se Sponsored Adr ((BNTX)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy:...
TipRanks 5d
BioNTech SE’s Promising Phase II Study on Advanced Solid TumorsBiontech Se Sponsored Adr ((BNTX)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at...
TipRanks 5d
BioNTech SE’s New Study on PM8002: A Potential Game-Changer in Colorectal Cancer TreatmentBiontech Se Sponsored Adr ((BNTX)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 5...
Analyst ratings
70%
of 23 ratingsBuy
69.6%
Hold
30.4%
Sell
0%
More BNTX News
TipRanks 5d
BioNTech SE’s Promising Phase 3 Study on NSCLC Treatment: A Potential Game-ChangerBiontech Se Sponsored Adr ((BNTX)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at...